Abstract
Insomnia has a significant global incidence rate. Previous observational studies, general practitioner surveys, and medical trials suggest that a variety of patient and physician factors are associated with this, including low patient reporting of insomnia, limited healthcare professional training, office-based time constraints, and misconceptions about the seriousness of insomnia, treatment benefits, and the risks associated with hypnotic use. Here, we discuss the recently studied genetic aspects of insomnia pathogenesis and the orexin system and acupuncture as potential therapeutic strategies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
